reported the FDA granted orphan drug designation for sirolimus (DE-109) to treat chronic/refractory anterior non-infectious uveitis, non-infectious intermediate uveitis, non-infectious panuveitis and non-infectious uveitis affecting the posterior segment of the eye

DuoCort Pharma AB, of Helsingborg, Sweden, said the European Commission granted European Marketing Authorization for Plenadren (hydrocortisone, modified-release tablet), an orphan drug for the treatment of adrenal insufficiency in adults

DuoCort Pharma AB, of Helsingborg, Sweden, said the European Commission granted European Marketing Authorization for Plenadren (hydrocortisone, modified-release tablet), an orphan drug for the treatment of adrenal insufficiency in adults

Atox Bio Inc., of Ness Ziona, Israel, said the FDA granted orphan drug designation for AB103 for the treatment of necrotizing soft tissue infections (NSTI

Celldex Therapeutics Inc., of Needham, Mass., said the European Medicines Agency granted orphan drug designation in the European Union for rindopepimut (CDX-110) for the treatment of glioblastoma...The FDA previously granted the drug orphan drug designation

Biovest International Inc., of Tampa, Fla., a majority-owned subsidiary of Accentia Biopharmaceuticals Inc., of Minneapolis, said the FDA granted orphan drug designation to BiovaxID for the treatment of Waldenstrom's macroglobulinemia, a rare subtype of B-cell non-Hodgkin's lymphoma...Previously, the company obtained orphan drug designation for BiovaxID in the U.S

The oral antiepileptic drug, a 1 ,5 benzodiazepine, was granted seven years' exclusivity as an orphan drug

Atox Bio Inc., of Ness Ziona, Israel, said the FDA granted orphan drug designation for AB103 for the treatment of necrotizing soft tissue infections (NSTI...Pinnacle Biologics Inc., of Bannockburn, Ill., filed an orphan drug designation for Photofrin (porfimer sodium) as adjuvant therapy to surgery in the treatment of malignant pleural mesothelioma

The oral antiepileptic drug, a 1,5 benzodiazepine, was granted seven years' exclusivity as an orphan drug

The FDA has granted orphan drug status to mechlorethamine gel

In return, Inspiration will issue a convertible note to Ipsen, bringing Ipsen's fully diluted equity ownership position in Inspiration to approximately 38 percent...Other Phase II results in ovarian and small-cell lung cancer showed long-term clinical benefit, and Phase I results established safety of a high dose level with two-hour infusion

ViroPharma said it also intends to file for orphan drug designation

4SC AG, of Planegg-Martinsried, Germany, reported that the FDA granted a second orphan drug designation, this one in Hodgkin's lymphoma (HL), to resminostat...The oral histone deacetylase inhibitor was recently granted orphan drug designation for hepatocellular carcinoma

4SC AG, of Planegg-Martinsried, Germany, reported that the FDA granted a second orphan drug designation, this one in Hodgkin's lymphoma (HL), to resminostat...The oral histone deacetylase inhibitor was recently granted orphan drug designation for hepatocellular carcinoma

Revimmune, by Accentia Biopharmaceuticals Inc., of Tampa, Fla., has been given orphan drug designation for prevention of graft-vs.-host disease

The company has orphan drug and fast-track status for HIV-PN and requested priority review

Kamada Ltd., of Ness Ziona, Israel, received orphan drug designation from the FDA for a Alpha-1 Antitrypsin (AAT), an investigational therapy for Type I diabetes

Kamada Ltd., of Ness Ziona, Israel, received orphan drug designation from the FDA for a Alpha-1 Antitrypsin (AAT), an investigational therapy for Type I diabetes

Phytopharm plc, of Godmanchester, UK, said the FDA granted orphan drug status to Cogane (PYM50028) for the treatment of amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease, the most prevalent form of motor neurone disease, Cogane has shown promising activity in vitro and in vivo models of ALS and a study of the product in an in vivo model is ongoing